ONCT insider transaction filings
Oncternal Therapeutics, Inc. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-06-24. Screen ONCT transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ONCT between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Oncternal Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-24 | 4 | THEUER CHARLES — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | DeSimone Jill — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | CARTER MICHAEL G — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Wills Robert James — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | LARUE WILLIAM R — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | MAZANET ROSEMARY — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | KISNER DANIEL L — Director | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | HALE DAVID F — Director | Grant/award (A): 3,300 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | Wills Robert James — Director | Purchase (P): 3,086 @ $8.96 | EDGAR |
| 2024-04-01 | 4 | Wills Robert James — Director | Purchase (P): 6,914 @ $8.48 | EDGAR |
| 2024-02-27 | 4 | Wills Robert James — Director | Sale (S): 980 @ $9.04 | EDGAR |
| 2024-02-27 | 4 | HALE DAVID F — Director | Purchase (P): 714 @ $9.04 · Purchase (P): 266 @ $9.04 | EDGAR |
| 2024-02-15 | 4 | Leavitt Chase C. — General Counsel/Secretary | Grant/award (A): 14,200 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Krishnan Rajesh — CTO/CSO | Grant/award (A): 17,700 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Yazji Salim — Chief Medical Officer | Grant/award (A): 14,200 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | VINCENT RICHARD G — Chief Financial Officer | Grant/award (A): 14,200 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | BREITMEYER JAMES B — Chief Executive Officer, Director | Grant/award (A): 28,400 (derivative) @ $0 · Grant/award (A): 6,200 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Krishnan Rajesh — Chief Technical Officer | Tax withholding (F): 11,838 @ $0.50 | EDGAR |
| 2024-01-05 | 4 | Yazji Salim — Chief Medical Officer | Tax withholding (F): 19,742 @ $0.50 | EDGAR |
| 2024-01-05 | 4 | VINCENT RICHARD G — Chief Financial Officer | Tax withholding (F): 8,868 @ $0.50 | EDGAR |
| 2024-01-05 | 4 | Leavitt Chase C. — General Counsel/Secretary | Tax withholding (F): 11,838 @ $0.50 | EDGAR |
| 2024-01-05 | 4 | BREITMEYER JAMES B — Chief Executive Officer, Director | Tax withholding (F): 50,955 @ $0.50 · Tax withholding (F): 4,485 @ $0.50 | EDGAR |
Recent 8-K events — Oncternal Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-11-25 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-11-14 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-09-12 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2024-08-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-05-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-05 | 8-K | 2.02 — Results of Operations and Financial Condition 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ONCT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →